Company Growth (employees)
Thermo Fisher Scientific was founded in 1956 and is headquartered in Waltham, US
Key People at Thermo Fisher Scientific
Marc Casper
President and Chief Executive Officer
Thermo Fisher Scientific Office Locations
Thermo Fisher Scientific has an office in Waltham
Waltham, US (HQ)
168 3rd Ave
Thermo Fisher Scientific Data and Metrics
Thermo Fisher Scientific Financial Metrics
Thermo Fisher Scientific's revenue was reported to be $18.3 b in FY, 2016 which is a 8% increase from the previous period.
USD
Revenue (FY, 2016) | 18.3 b |
Revenue growth (FY, 2015 - FY, 2016), % | 8% |
Gross profit (FY, 2016) | 8.4 b |
Gross profit margin (FY, 2016), % | 46% |
Net income (FY, 2016) | 2 b |
EBIT (FY, 2016) | 2.4 b |
Market capitalization (19-Jul-2017) | 70.5 b |
Closing share price (19-Jul-2017) | 179.4 |
Cash (31-Dec-2016) | 786.2 m |
EV | 86.3 b |
Thermo Fisher Scientific's current market capitalization is $70.5 b.
- Source: SEC Filings
| USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|
Revenue | 13.1 b | 16.9 b | 17 b | 18.3 b |
Revenue growth, % | 29% | 0% | 8% | |
Cost of goods sold | 7.6 b | 9.4 b | 9.2 b | 9.9 b |
Gross profit | 5.5 b | 7.5 b | 7.8 b | 8.4 b |
Gross profit Margin, % | 42% | 44% | 46% | 46% |
Operating expense total | 11.5 b | 14.4 b | 14.6 b | 15.8 b |
EBIT | 1.6 b | 2.5 b | 2.3 b | 2.4 b |
EBIT margin, % | 12% | 15% | 14% | 13% |
Pre tax profit | 1.3 b | 2.1 b | 1.9 b | 2 b |
Income tax expense | (40.4 m) | (191.7 m) | 43.9 m | 1.4 m |
Net Income | 1.3 b | 1.9 b | 2 b | 2 b |
- Source: SEC Filings
| USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|
Cash | 5.8 b | 1.3 b | 452.1 m | 786.2 m |
Inventories | 1.5 b | 1.9 b | 2 b | 2.2 b |
Current Assets | 9.9 b | 6.5 b | 5.7 b | 7 b |
PP&E | 1.8 b | 2.4 b | 2.4 b | 2.6 b |
Goodwill | 12.5 b | 18.8 b | 18.8 b | 21.3 b |
Total Assets | 31.9 b | 42.9 b | 40.9 b | 45.9 b |
Accounts Payable | 691.5 m | 820.7 m | 822.2 m | 926.2 m |
Total Debt | 10.5 b | 14.6 b | 12.5 b | 16.6 b |
Current Liabilities | 3.1 b | 5.3 b | 4.1 b | 4.9 b |
Additional Paid-in Capital | 8.2 b | 11.5 b | 11.8 b | 12.1 b |
Retained Earnings | 8.8 b | 10.4 b | 12.1 b | 13.9 b |
Total Equity | 16.9 b | 20.5 b | 21.4 b | 21.5 b |
EPS | 3.6 | 4.8 | 5 | 5.1 |
Debt to Equity Ratio | 0.6 x | 0.7 x | 0.6 x | 0.8 x |
Debt to Assets Ratio | 0.3 x | 0.3 x | 0.3 x | 0.4 x |
Financial Leverage | 1.9 x | 2.1 x | 1.9 x | 2.1 x |
| USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|
Net Income | 1.3 b | 1.9 b | 2 b | 2 b |
Accounts Receivable | (147.9 m) | (145.4 m) | (149.4 m) | (352.2 m) |
Inventories | (72.2 m) | (109.8 m) | (140.7 m) | 97.8 m |
Accounts Payable | 47 m | 1.2 m | (2.7 m) | 55.5 m |
Cash From Operating Activities | 2 b | 2.6 b | 2.8 b | 3.2 b |
Capital Expenditures | (282.4 m) | (427.6 m) | (422.9 m) | (444.4 m) |
Cash From Investing Activities | (263.3 m) | (11.8 b) | (1.1 b) | (5.5 b) |
Dividends Paid | (216.2 m) | (234.8 m) | (240.6 m) | (238.4 m) |
Cash From Financing Activities | 3.3 b | 4.8 b | (2.5 b) | 2.9 b |
Free Cash Flow | 2.3 b | 3 b | 3.2 b | 3.6 b |
| USD | Y, 2016 |
|---|---|
P/E Ratio | 35 |
EV/EBIT | 35.2 x |
EV/CFO | 27.3 x |
EV/FCF | 24 x |
Revenue/Employee | 351.4 k |
Debt/Equity | 0.8 x |
Debt/Assets | 0.4 x |
Financial Leverage | 2.1 x |
Thermo Fisher Scientific Operating Metrics
Thermo Fisher Scientific's Customers was reported to be 400 k in FY, 2016
- Source: SEC Filings
Thermo Fisher Scientific Acquisitions / Subsidiaries
| Acquired Company | Date | Deal Size |
|---|---|---|
| Core Informatics | March 07, 2017 |
Thermo Fisher Scientific Market Value History
Thermo Fisher Scientific Revenue Breakdown
Thermo Fisher Scientific Median Salaries
Source: 125 public H-1B filings from Thermo Fisher Scientific
